Over the last 12 months, Labcorp Holdings insiders reported no purchases and 5 sales totaling $1.0M across SEC Form 4 filings. 60% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Summy Amy B.EVP, Chief Marketing Officer · O | ▼ Sale | 924 | $306.74 | $283K | -11.7% | — |
| Aug 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer · O | ▼ Sale | 1,420 | $309.23 | $439K | -44.5% | 2 tranches |
| Jul 2, 2026 | Kyle Kathryn WEVP, Chief Legal Officer · O | ▼ Sale | 92 | $286.19 | $26K | -2.3% | plan |
| Jul 2, 2026 | Vaughn Bryan TEVP and President, Diagnostics · O | ▼ Sale | 234 | $286.19 | $67K | -3.4% | plan |
| Jun 8, 2026 | Kyle Kathryn WEVP, Chief Legal Officer · O | ▼ Sale | 762 | $263.89 | $201K | -16.7% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $LH feed.